Biblio

Export 137 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
S. Wolfsgruber, Polcher, A., Koppara, A., Kleineidam, L., Frölich, L., Peters, O., Hüll, M., Rüther, E., Wiltfang, J., Maier, W., Kornhuber, J., Lewczuk, P., Jessen, F., and Wagner, M., “Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 58, no. 3, pp. 939-950, 2017.
S. Wolfsgruber, Kleineidam, L., Wagner, M., Mösch, E., Bickel, H., Lϋhmann, D., Ernst, A., Wiese, B., Steinmann, S., König, H. - H., Brettschneider, C., Luck, T., Stein, J., Weyerer, S., Werle, J., Pentzek, M., Fuchs, A., Maier, W., Scherer, M., Riedel-Heller, S. G., and Jessen, F., “Differential Risk of Incident Alzheimer's Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1135-1146, 2016.
K. Wittfeld, Raman, M. R., Conner, S. C., Aslam, A., Teumer, A., Nauck, M., Hosten, N., Habes, M., DeCarli, C., Vasan, R. S., Beiser, A. S., Himali, J. J., Seshadri, S., Grabe, H. J., and Satizabal, C. L., “Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults.”, J Alzheimers Dis, vol. 88, no. 1, pp. 311-32, 2022.
A. L. Wiseman, Briggs, C. A., Peritt, A., Kapecki, N., Peterson, D. A., Shim, S. S., and Stutzmann, G. E., “Lithium Provides Broad Therapeutic Benefits in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 91, no. 1, pp. 273-290, 2023.
C. M. Wischik, Schelter, B. O., Wischik, D. J., Storey, J. M. D., and Harrington, C. R., “Modeling Prion-Like Processing of Tau Protein in Alzheimer's Disease for Pharmaceutical Development.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1287-1303, 2018.
K. J. Wirth, “Role of Noradrenergic Brain Nuclei in the Regulation of Carotid Artery Blood Flow: Pharmacological Evidence from Anesthetized Pigs with Alpha-2 Adrenergic Receptor Modulator Drugs.”, J Alzheimers Dis, vol. 66, no. 1, pp. 407-419, 2018.
C. N. Winston, Goetzl, E. J., Baker, L. D., Vitiello, M. V., and Rissman, R. A., “Growth Hormone-Releasing Hormone Modulation of Neuronal Exosome Biomarkers in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 3, pp. 971-981, 2018.
C. N. Winston, Aulston, B., Rockenstein, E. M., Adame, A., Prikhodko, O., Dave, K. N., Mishra, P., Rissman, R. A., and Yuan, S. H., “Neuronal Exosome-Derived Human Tau is Toxic to Recipient Mouse Neurons in vivo.”, J Alzheimers Dis, vol. 67, no. 2, pp. 541-553, 2019.
C. N. Winston, Langford, O., Levin, N., Raman, R., Yarasheski, K., West, T., Abdel-Latif, S., Donohue, M., Nakamura, A., Toba, K., Masters, C. L., Doecke, J., Sperling, R. A., Aisen, P. S., and Rissman, R. A., “Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 95-107, 2023.
A. Winkler, Weimar, C., Jöckel, K. - H., Erbel, R., Dragano, N., Broecker-Preuss, M., Moebus, S., Führer-Sakel, D., and Dlugaj, M., “Thyroid-Stimulating Hormone and Mild Cognitive Impairment: Results of the Heinz Nixdorf Recall Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 797-807, 2016.
R. Wingbermühle, Wen, K. - X., Wolters, F. J., M Ikram, A., and Bos, D., “Smoking, APOE Genotype, and Cognitive Decline: The Rotterdam Study.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1191-1195, 2017.
A. Wimo, “The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View.”, J Alzheimers Dis, 2018.
A. Wimo, Belger, M., Bon, J., Jessen, F., Dumas, A., Kramberger, M. G., Jamilis, L., Johansson, G., Salas, A. Rodrigo, Gómez, O. Rodríguez, Sannemann, L., Stoekenbroek, M., Telleria, M. Gurruchaga, Valero, S., Vermunt, L., Waterink, L., Winblad, B., Visser, P. Jelle, Zwan, M., and Boada, M., “A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1149-1159, 2021.
A. Wimo, Sjölund, B. - M., Sköldunger, A., Qiu, C., Klarin, I., Nordberg, G., and von Strauss, E., “Cohort Effects in the Prevalence and Survival of People with Dementia in a Rural Area in Northern Sweden.”, J Alzheimers Dis, vol. 50, no. 2, pp. 387-96, 2016.
E. N. Wilson, Carmo, S. Do, Welikovitch, L. A., Hall, H., Aguilar, L. Flores, Foret, M. K., M Iulita, F., Jia, D. Tong, Marks, A. R., Allard, S., Emmerson, J. T., Ducatenzeiler, A., and A Cuello, C., “NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats.”, J Alzheimers Dis, vol. 73, no. 2, pp. 723-739, 2019.
S. M. Williams, Schulz, P., Rosenberry, T. L., Caselli, R. J., and Sierks, M. R., “Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 23-35, 2017.
K. Willén, Sroka, A., Takahashi, R. H., and Gouras, G. K., “Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.”, J Alzheimers Dis, vol. 60, no. 2, pp. 511-524, 2017.
E. A. J. Willemse, Durieux-Lu, S., van der Flier, W. M., Pijnenburg, Y. A. L., de Jonge, R., and Teunissen, C. E., “Stability of Progranulin Under Pre-Analytical Conditions in Serum and Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 53, no. 1, pp. 107-16, 2016.
H. M. Wilkins, Mahnken, J. D., Welch, P., Bothwell, R., Koppel, S., Jackson, R. L., Burns, J. M., and Swerdlow, R. H., “A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.”, J Alzheimers Dis, vol. 59, no. 1, pp. 291-300, 2017.
H. M. Wilkins, Troutwine, B. R., Menta, B. W., Manley, S. J., Strope, T. A., Lysaker, C. R., and Swerdlow, R. H., “Mitochondrial Membrane Potential Influences Amyloid-β Protein Precursor Localization and Amyloid-β Secretion.”, J Alzheimers Dis, vol. 85, no. 1, pp. 381-394, 2021.
E. H. Wilker, Martinez-Ramirez, S., Kloog, I., Schwartz, J., Mostofsky, E., Koutrakis, P., Mittleman, M. A., and Viswanathan, A., “Fine Particulate Matter, Residential Proximity to Major Roads, and Markers of Small Vessel Disease in a Memory Study Population.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1315-23, 2016.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., “Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.”, J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
P. Wijesinghe, Shankar, S. K., Yasha, T. C., Gorrie, C., Amaratunga, D., Hulathduwa, S., K Kumara, S., Samarasinghe, K., Suh, Y. - H., Steinbusch, H. W. M., and K De Silva, R. D., “Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1607-1618, 2016.
H. E. Whitson, Potter, G. G., Feld, J. A., Plassman, B. L., Reynolds, K., Sloane, R., and Welsh-Bohmer, K. A., “Dual-Task Gait and Alzheimer's Disease Genetic Risk in Cognitively Normal Adults: A Pilot Study.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1137-1148, 2018.
B. White, Lyketsos, C. G., Rosenberg, P. B., Oh, E. S., and Chen, L., “Multiple Neurodegenerative Pathologies in an Alzheimer's Disease Patient Treated with Fornical Deep Brain Stimulation.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1383-1387, 2021.

Pages